JAK1 and cancer: JAK1 is an obligatory molecule subserving downstream signaling from the IFNγ receptor and JAK1 loss is well described as an immunologic escape mechanism in dMMR colorectal cancer (39) and as a resistance mechanism to checkpoint blockade in immunogenic cancers (40).